Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Chronomics

Chronomics
2017 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Seed LATEST DEAL TYPE
$1.46M LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of an artificial intelligence platform intended to perform epigenetic testing. The company's platform utilizes the predictive power of DNA methylation biomarkers, enabling health-conscious individuals to gain useful insights and seek proactive care based on genetic factors.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Software
Other Services (B2C Non-Financial)
Primary Office
  • London
  • England, United Kingdom
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Chronomics’s full profile, request a free trial.

Chronomics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 09-Jan-2019 $1.46M 00.000 Completed Startup
1. Accelerator/Incubator 22-Dec-2017 00000 00000 00.00 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Chronomics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Anthemis Group Venture Capital Minority 000 0000 000000 0
SOSV Venture Capital Minority 000 0000 000000 0

Chronomics Executive Team (4)

Name Title Board
Seat
Contact
Info
Thomas Stubbs Ph.D Chief Executive Officer & Co-Founder
Toby Call Ph.D Chief Financial Officer & Co-Founder
Charles Ball Chief Operating Officer & Co-Founder
Daniel Herranz Ph.D Chief Technology Officer & Co-Founder